World Health Organization
Moderna’s updated COVID-19 mRNA vaccine approved by MHRA
The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme
Pfizer and BioNTech’s XFG-adapted COVID-19 vaccine approved by US FDA
The 2026-2027 vaccine targets the XFG variant to more closely match current variants
WHO releases new target product profiles for urgently needed antibiotics
The antibiotics are needed to combat key drug-resistant bacteria causing severe bloodstream and urinary tract infections, pneumonia and meningitis
MHRA marks 100 years of patient safety through biological standards
The UK regulator highlights its century-long role in establishing safety and consistency benchmarks
Lilly and WHO Foundation partner to support global dementia action plan
The partnership will provide financial support and strengthen early detection and intervention efforts
University of Liverpool identifies new class of antibiotic in fight against AMR
The new antibiotic class targets two of the WHO’s ‘priority pathogens’
Invivyd working with FDA towards potential Biologics License Application for COVID-19
The company plans head-to-head safety evaluation with COVID-19 vaccine, pending regulatory alignment
FDA approves Pfizer and BioNTech’s jab for COVID-19
Globally, five billion doses of the companies’ vaccine have been distributed
Moderna’s LP.8.1-adapted COVID-19 vaccine recommended by CHMP
Global health authorities have recommended that vaccines for the 2025-2026 season should target LP.8.1
EC approves CSL/Arcturus’ self-amplifying mRNA COVID-19 vaccine Kostaive
Kostaive is designed to instruct the body to make more mRNA to boost immune response
WHO urges US to ‘reconsider’ withdrawal from global health organisation
President Donald Trump said the agency mishandled the COVID-19 pandemic and other global health crises
WHO launches $1.5bn emergency appeal to tackle ongoing health crises
The appeal is aimed at providing urgent humanitarian assistance to more than 300 million people